HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Toshikatsu Shibata Selected Research

Transcription Factors (Transcription Factor)

7/2006An inhibitory effect of A20 on NF-kappaB activation in airway epithelium upon influenza virus infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Toshikatsu Shibata Research Topics

Disease

9Infections
06/2023 - 06/2003
5Neoplasms (Cancer)
08/2020 - 04/2002
3Human Influenza (Influenza)
08/2018 - 03/2009
3Virus Diseases (Viral Diseases)
01/2018 - 06/2003
3Neoplasm Metastasis (Metastasis)
01/2008 - 02/2002
3Stomach Neoplasms (Stomach Cancer)
01/2008 - 04/2002
2Pneumonia (Pneumonitis)
08/2018 - 07/2006
2Breast Neoplasms (Breast Cancer)
06/2005 - 11/2003
2Neoplasm Micrometastasis
05/2003 - 02/2002
1Acute Liver Failure (Fulminant Hepatic Failure)
06/2023
1Acute-On-Chronic Liver Failure
06/2023
1Hepatocellular Carcinoma (Hepatoma)
02/2022
1Pancreatic Neoplasms (Pancreatic Cancer)
08/2020
1Adenocarcinoma
08/2020
1Non-alcoholic Fatty Liver Disease
07/2018
1Fibrosis (Cirrhosis)
07/2018
1Leukemia
03/2009
1Lymphatic Metastasis
06/2005
1Gallbladder Neoplasms (Gallbladder Cancer)
05/2005
1Carcinoma (Carcinomatosis)
05/2005
1Body Weight (Weight, Body)
06/2003
1Coinfection
06/2003
1Colorectal Neoplasms (Colorectal Cancer)
05/2003

Drug/Important Bio-Agent (IBA)

8Proteins (Proteins, Gene)FDA Link
07/2018 - 11/2003
2Hepatitis A AntibodiesIBA
06/2023 - 02/2022
2Subgenomic RNAIBA
02/2022 - 01/2022
2RNA (Ribonucleic Acid)IBA
08/2020 - 01/2018
2Messenger RNA (mRNA)IBA
07/2006 - 05/2005
2Telomerase (Telomerase Reverse Transcriptase)IBA
06/2005 - 11/2003
2Fluorescein (Funduscein)FDA LinkGeneric
01/2004 - 04/2002
2Keratins (Keratin)IBA
05/2003 - 02/2002
2Coloring Agents (Dyes)IBA
05/2003 - 02/2002
1masitinibIBA
06/2023
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
01/2023
1Niacinamide (Nicotinamide)FDA LinkGeneric
01/2023
1NucleotidesIBA
02/2022
1Antiviral Agents (Antivirals)IBA
02/2022
1favipiravirIBA
02/2022
1RimantadineFDA LinkGeneric
01/2022
1Amantadine (Aman)FDA LinkGeneric
01/2022
1InterferonsIBA
08/2020
1Poly I-CIBA
08/2020
1Toll-Like Receptors (Toll-Like Receptor)IBA
08/2020
1DNA (Deoxyribonucleic Acid)IBA
01/2020
1PowdersIBA
08/2018
1CytokinesIBA
07/2018
1CaspasesIBA
07/2018
1JNK Mitogen-Activated Protein KinasesIBA
07/2018
1InflammasomesIBA
07/2018
1Viral ProteinsIBA
01/2018
1VaccinesIBA
01/2015
1Methanol (Carbinol)IBA
03/2009
1Staphylococcal Protein A (Protein A)IBA
03/2009
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2008
1NucleolinIBA
11/2007
1Transcription Factors (Transcription Factor)IBA
07/2006
1NF-kappa B (NF-kB)IBA
07/2006
1Indicators and Reagents (Reagents)IBA
06/2005
1apomucinIBA
05/2005
1Homeodomain Proteins (Proteins, Homeobox)IBA
05/2005
1CDX2 Transcription FactorIBA
05/2005
1Cytidine DeaminaseIBA
06/2003
1Monoclonal AntibodiesIBA
06/2003
1AntibodiesIBA
06/2003
1Immunoglobulin M (IgM)IBA
06/2003
1Neutralizing AntibodiesIBA
06/2003
1Immunoglobulins (Immunoglobulin)IBA
06/2003
1Immunoglobulin G (IgG)IBA
06/2003
1bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA
05/2003

Therapy/Procedure

1Intranasal Administration
08/2018
1Lasers (Laser)
11/2007